Naveris logo

Naveris

Brand · Biotechnology Research

3.8

Company overview

Naveris® Inc. is a molecular diagnostics company developing and commercializing novel blood and saliva tests to enhance the early detection and clinical management of viral-associated cancers. The company’s NavDx® blood test, which uses proprietary technology to detect tumor tissue modified viral (TTMV®)-HPV DNA, is in use at leading cancer treatment centers and academic medical centers throughout the United States.www.naveris.comwww.navdx.com
Founded in 2017
Waltham, Massachusetts, USA
115 employees (5 in marketing)
www.naveris.com
53% recommend to a friend
78% positive business outlook

Salaries

Typical salary range

$70,000 – $100,000

/ yr

Help build salary transparency at Naveris

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

1 open now

Headcount trend

Company growth over the last 12 months

Headcount +23.2% year over year

Funding

Total funding

$66.3M

Last raise

$17.5M

Series Unknown, 2 years ago

Funding history

Jul 2024

Venture Round Naveris · $17.5M

Sep 2022

Series A Naveris · $33.4M

Dec 2020

Series A Naveris

Feb 2020

Venture Round Naveris · $15.4M

Nov 2019

Seed Round Naveris

Audience

Monthly website visitors
2.4K
Month over month-56.5%
Quarter over quarter-51.5%
Top sourceDirect (48.3%)
Ad budget per month$0.0
Average search rank46.2
Traffic source mix
Direct
48.3%
Search
27.3%
Social
16.9%
Referral
6%
Paid referral
1.4%

LinkedIn followers

Follower count and growth

Total followers

8.4K

12-mo growth

+47.9%

Monthly growth

+5.3%

News

Links

www.naveris.comLinkedInCrunchbaseX (Twitter)
Glassdoor